A global non-profit organization offering CME programs for healthcare professionals. Join our conversations around the latest medical conferences & courses.
Somerville, NJ
Joined May 2023
- Tweets670
- Following89
- Followers18
- Likes214
Pinned Tweet
We鈥檙e thrilled to announce that eMedEd has been awarded 饾悁饾悅饾悅饾悓饾悇 饾悮饾悳饾悳饾惈饾悶饾悵饾悽饾惌饾悮饾惌饾悽饾惃饾惂 as a trusted provider of continuing medical education (CME).
Learn more : bit.ly/4geIDGM
#CME #CE #Accreditation #Healthcare #globalCME #eMedEd #ACCME
As MS care moves toward earlier intervention, the questions around treatment decisions & long-term management become increasingly important.
At #ANS2026, #eMedEd brings the neurology community together to explore the evolving evidence and its implications for clinical practice.
MS care has shifted from relapse control to early intervention. Our latest article breaks down what鈥檚 changing and the tough questions clinicians face as a result. These key considerations and more will be part of the discussion at #ANS2026 on Nov 14-15 in Orlando, FL.
Read the full article: ow.ly/9nAi5100zw1
#Neurotwitter #MultipleSclerosis #NeurologyCME #eMedEvents #eMedEd
What an incredible two days at #HerHealth2026.
Grateful to everyone who contributed to the conversations, shared their expertise, and made this community so special.
The learning continues, and we鈥檙e already looking ahead to #HerOncology2027!
#Oncology #eMedEvents #eMedEd
Two days of insight, dialogue, and discovery, from emerging therapies and biomarkers to immunotherapy, AI, and translating evidence into practice.
To every speaker, exhibitor, and attendee: thank you for being part of the conversations that will continue long after the conference ends.
#HerHealth2026 may be over but its impact continues with #HerOncology2027.
#eMedEvents #eMedEd #WomensOncology #GynecologicOncology #Oncology #CME
What a day of meaningful conversations, fresh perspectives, and shared expertise.
Grateful to all the faculty who made #HerHealth2026 such a rich learning experience & for the insights that will continue to inform care well beyond the conference.
#Oncology #eMedEvents #eMedEd
From cancer care and biomarkers to AI and translating evidence into practice, today鈥檚 faculty brought valuable perspectives to #HerHealth2026.
Thank you to all the speakers for sharing their expertise and insights that extend beyond the conference.
#Oncotwitter #GynOnco #MedicalOncology #CervicalCancer #OvarianCancer #GynecologicCancer #eMedEvents #eMedEd
How does new knowledge shape clinical practice?
In the final session of #HerHealth2026, our Conference Chair, Ursula Matulonis, MD, connects key takeaways from across the conference to clinical decisions.
#GynecologicOncology #Oncology #CME #eMedEvents #eMedEd
As #HerHealth2026 nears its final session, our Conference Chair, Ursula Matulonis, MD, brings the meeting鈥檚 insights into focus with 'Translating Evidence Into Practice', connecting evidence, evolving strategies, and key takeaways from across the conference.
#GynecologicOncology #Oncotwitter #MedicalOncology #WomensOncology #Oncology #CME #eMedEvents #eMedEd
As oncology therapies evolve, so does the need to recognize and manage treatment-related toxicities.
At #HerHealth2026, Vicky Makker, MD, explores practical approaches to adverse event management.
#ToxicityManagement #Immunotherapy #Oncology #CME #CE #eMedEvents #eMedEd
As cancer treatments evolve, so does the need to manage their complexities.
At #HerHealth2026, Vicky Makker, MD, explores IO, ADC, and targeted therapy toxicities in modern oncology.
#ToxicityManagement #Immunotherapy #Oncology #Oncotwitter #BreastCancer #OvarianCancer #CME #CE #eMedEvents #eMedEd
At #HerHealth2026, Constance Lehman, MD, PhD, explores practical applications and how emerging technologies are being integrated into clinical practice.
#AIinHealthcare #Oncology #BreastCancer #GynecologicOncology #CME #eMedEvents #eMedEd
Beyond the AI headlines, where does it truly make a difference in cancer care?
Constance Lehman, MD, PhD, explores real-world AI applications in breast and gynecologic oncology, and where innovation is creating practical clinical value.
#AIinHealthcare #Oncology #BreastCancer #GynecologicOncology #WomensOncology #CME #eMedEvents #eMedEd
At #HerHealth2026, Bhavana Pothuri, MD, gives us a closer look at where biomarkers can inform care and where their limitations should guide clinical judgment.
This activity is supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., Lilly USA, and Exact Sciences.
When can biomarkers truly influence care? At #HerHealth2026, Bhavana Pothuri, MD, examines their role in women鈥檚 cancers from clinical utility and implementation to the limitations that shape their use.
This activity is supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., Lilly USA, and Exact Sciences.
#GynecologicOncology #WomensCancer #OvarianCancer
eMedEd retweeted
Proud to have these partners with us at #HerHealth2026!
We鈥檙e pleased to recognize the sponsors and exhibitors supporting this year鈥檚 event and for helping bring together the breast and gynecologic oncology community for two days of focused clinical exchange.
Meet the exhibitors that are part of #HerHealth2026!
#WomensOncology #Exhibitors #GynecologicOncology #Oncology #eMedEvents
From therapy to everyday well-being, this session by Tarun Wasil, MD, looks at the broader factors that support the patient journey.
#CancerCare #WomensOncology #Oncology #CME #CE #eMedEvents #eMedEd
Cancer care goes beyond treatment. What else can make a difference?
At #HerHealth2026, Tarun Wasil, MD, explores how lifestyle and comprehensive management can complement modern cancer care.
#Medtwitter #Oncotwitter #OncologyCME #GynecologicCancer #BreastCancer #WomensHealth #eMedEvents #eMedEd
What鈥檚 changing in cervical cancer care and what should clinicians take forward?
Bhavana Pothuri, MD explores current standards and emerging regimens at #HerHealth2026.
#CervicalCancer #GynecologicOncology #Oncology #CME #CE #eMedEvents #eMedEd
What鈥檚 changing in cervical cancer care? The conversation is underway at #HerHealth2026.
Bhavana Pothuri, MD, explores current standards and emerging regimens in the evolving immunotherapy era, giving us a closer look at what鈥檚 next in cervical cancer treatment.
#Oncotwitter #GynOnco #OncologyCME #GynecologicCancer #CervicalCancer #GynecologicOncology #WomensCancer #OvarianCancer #eMedEvents #eMedEd
At #HerHealth2026, Ursula Matulonis, MD, explores the new evidence helping refine how clinicians approach treatment decisions for endometrial cancer.
This activity is supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.
#GynecologicCancer #EndometrialCancer
Molecular insights are shaping the next steps in endometrial cancer care at #HerHealth2026.
Ursula Matulonis, MD, explores molecular classification, treatment decisions, and emerging therapies across newly diagnosed and recurrent disease.
This activity is supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.
#Oncotwitter #GynOnco #GynecologicCancer #EndometrialCancer #GynecologicOncology #WomensCancer #OvarianCancer
At #HerHealth2026, Ursula Matulonis, MD & Dmitriy Zamarin, MD, examine where patient-centered insight and evidence can guide treatment decisions.
This independent satellite symposium is supported by educational grants from Merck (MSD), Daiichi Sankyo, Inc., and Lilly USA.
At #HerHealth2026, the focus turns to platinum-resistant ovarian cancer and the evolving approaches to treatment.
Ursula Matulonis, MD, and Dmitriy Zamarin, MD, bring patient-centered insights and evidence-based strategies into the discussion. Exploring new ways to navigate treatment challenges in ovarian cancer care.
This independent satellite symposium is supported by educational grants from Merck (MSD), Daiichi Sankyo, Inc., and Lilly USA.
#Oncology #GynecologicOncology #GynecologicCancer #WomensCancer #OvarianCancer
At #HerHealth2026, Dmitriy Zamarin, MD, gives us a closer look at how the treatment landscape is changing and what it could mean for clinical practice.
#Oncotwitter #GynOnco #OncologyCME #GynecologicCancer #WomensCancer #OvarianCancer #eMedEvents #eMedEd
The conversation begins with ovarian cancer at #HerHealth2026, exploring frontline therapy, emerging evidence, and early signs of resistance.
Join us as Dmitriy Zamarin, MD, brings the evolving treatment landscape into focus.
Follow the conversation and discover what鈥檚 next for ovarian cancer care.
#Oncotwitter #GynOnco #OncologyCME #GynecologicCancer #WomensCancer #OvarianCancer #CME #CE #eMedEvents #eMedEd
30 minutes to go.
The stage is set for Day 2 of #HerHealth2026!
#MedicalOncology #GynecologicOncology #GynecologicCancer #WomensHealth #OvarianCancer #eMedEd
This quoted post is unavailable.
Day One at #HerHealth2026 brought together leading experts, evolving evidence, and important advances across breast and gynecologic oncology.
Day Two begins tomorrow, with the focus turning to gynecologic oncology.
Stay tuned!
Day 1 of #HerHealth2026 has concluded.
From evolving breast cancer therapies and rare gynecologic malignancies to targeted therapy in recurrent LGSOC, today鈥檚 sessions delivered current evidence, emerging treatment insights, and practice-relevant perspectives across women鈥檚 cancer care.
Thank you to all our speakers, exhibitors and attendees for joining us today.
Day Two begins tomorrow. Follow along for live updates!
#Oncotwitter #Medtwitter #MedicalOncology #BreastCancer #OvarianCancer #WomensCancer #OncologyCME #eMedEvents #eMedEd
Targeted therapy is reshaping treatment in recurrent LGSOC at #HerHealth2026.
Ursula Matulonis, MD, examines how emerging options can influence treatment strategy & patient care. This Independent Satellite Symposium is supported by an educational grant from Verastem Inc.
A new era in recurrent LGSOC is now in focus at #HerHealth2026.
Ursula Matulonis, MD, is discussing how targeted therapy is influencing treatment strategy and clinical decision-making in recurrent ovarian cancer. This Independent Satellite Symposium is supported by an educational grant from Verastem Inc.
#OvarianCancer #GynecologicOncology #Oncotwitter #Medtwitter #Oncology #eMedEvents
At #HerHealth2026, the Breast Cancer Tumor Board puts complex scenarios into focus through interactive Q&A and expert perspectives on real-world treatment decisions.
#BreastCancer #BreastOncology #TumorBoard #Oncology #CME #eMedEd
Complex breast cancer cases take center stage at #HerHealth2026.
The Breast Cancer Tumor Board is now underway, with Erica L. Mayer, MD, moderating an interactive Q&A with Rachel Grisham, MD, Shanu Modi, MD, and Tiffany Traina, MD, discussing challenging clinical scenarios and the considerations guiding treatment decisions.
#Oncotwitter #Medtwitter #OncologyCME #BreastCancer #WomensCancer #CME #CE #eMedEvents #eMedEd
Rare gynecologic cancers demand a closer clinical look.
At #HerHealth2026, Rachel Grisham, MD, explores the factors shaping diagnosis and treatment in these uncommon malignancies.
#GynecologicOncology #RareCancers #eMedEd
Rare gynecologic malignancies are now in focus at #HerHealth2026.
Rachel Grisham, MD, is examining the distinct biology, diagnostic considerations, and treatment approaches that can shape care for these uncommon cancers.
#Oncotwitter #Medtwitter #OncologyCME #GynecologicOncology #WomensCancer #eMedEvents #eMedEd
New treatment approaches are changing the TNBC landscape.
At #HerHealth2026, Tiffany Traina, MD, explores the evolving role of immunotherapy and ADCs in treatment strategy.
#BreastCancer #TNBC #BreastOncology #OncologyCME #eMedEd
As treatment options expand, the strategy for triple-negative breast cancer continues to evolve at #HerHealth2026.
Tiffany Traina, MD, examines how immunotherapy and ADCs are reshaping TNBC care, highlighting the evolving evidence and treatment approaches influencing clinical practice.
#Oncotwitter #Medtwitter #OncologyCME #BreastCancer #WomensCancer #TNBC #ADCs #CME #CE #eMedEvents #eMedEd
Shanu Modi, MD, shares her insights on the changing landscape of HER2-positive and HER2-low breast cancer and what emerging evidence means for treatment decisions.
#BreastCancer #Oncology #eMedEd
New evidence is reshaping HER2-positive and HER2-low breast cancer care.
At #HerHealth2026, Shanu Modi, MD, highlights the advances influencing HER2-directed treatment strategies and clinical practice.
#Medtwitter #Oncotwitter #BreastCancer #WomensCancer #CME #CE #eMedEvents #eMedEd
